Biologics

RTI Surgical(R) Announces Renewal of Supply and Distribution Agreement with Zimmer, Inc. for Its Trauma Business

RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a global surgical implant company, announced today that the company’s wholly owned subsidiary, Pioneer Surgical Technology Inc. DBA RTI Surgical, has signed an agreement with Zimmer, Inc. (NYSE:ZMH) (SWX:ZMH) to supply integrated plates and cables, cannulated screws and instrumentation for Zimmer’s trauma business.

Under the agreement, the company will manufacture the metal products at its Marquette, MI facility for distribution by Zimmer Trauma.

“Zimmer is pleased to continue its long-standing collaborative relationship with RTI Surgical,” said Nathan Folkert, president, Zimmer Trauma. “They have been a valuable supplier for more than a decade, and I am excited they will continue to help us accomplish our mission of delivering innovative products to surgeons and patients around the world.”

“Zimmer Trauma has a long-standing tradition of serving surgeons in trauma care and we believe our products offer the best in ease-of-use and quality,” said Brian K. Hutchison, president and chief executive officer, RTI Surgical. “We look forward to reaching more surgeons and patients with an industry-leading distributor like Zimmer.”

About RTI Surgical Inc.

RTI Surgical is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to advancing science, safety and innovation, RTI’s implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures and are distributed in nearly 50 countries. RTI is headquartered in Alachua, Fla., and has four manufacturing facilities throughout the U.S. and Europe. RTI is accredited in the U.S. by the American Association of Tissue Banks and is a member of AdvaMed. For more information, please visit www.rtix.com.

About Zimmer Inc.

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer’s 2013 sales were approximately $4.6 billion. The Company is supported by the efforts of more than 9,000 employees worldwide. More information about Zimmer is available at www.zimmer.com.

Zimmer Trauma is a business unit of Zimmer Holdings, Inc. Zimmer Trauma offers a comprehensive specialized portfolio of orthopaedic Trauma implants and instruments, designed to give surgeons uncompromising surgical solutions. Zimmer Trauma brands include: XtraFix(R), Zimmer Natural Nail(R) and NCB(R) Polyaxial Locking Plate System.

Forward-Looking Statement

This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management’s beliefs and certain assumptions made by our management. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, except for historical information, any statements made in this communication about anticipated financial results, growth rates, new product introductions, future operational improvements and results or regulatory actions or approvals or changes to agreements with distributors also are forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company’s SEC filings may be obtained by contacting the company or the SEC or by visiting RTI’s website at www.rtix.com or the SEC’s website at www.sec.gov.

 
    CONTACT: RTI Surgical Inc.

Robert Jordheim

Chief Financial Officer

rjordheim@rtix.com

or

Jenny Highlander, APR, 386-418-8888

Director, Corporate Communications

jhighlander@rtix.com

 
    SOURCE: RTI Surgical Inc. 
Copyright Business Wire 2014

Order free Annual Report for RTI Surgical, Inc.

Visit http://djnweurope.ar.wilink.com/?ticker=US74975N1054 or call +44 (0)208 391 6028

Order free Annual Report for Zimmer Holdings, Inc.

Visit http://djnweurope.ar.wilink.com/?ticker=US98956P1021 or call +44 (0)208 391 6028

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button